Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Health Canada

Hexo Makes Leadership Changes, Appoints New CEO & CFO

HEXO Corp (NASDAQ: HEXO) (TSX:HEXO) announced that Charlie Bowman has been appointed the company’s acting president and CEO.

Benzinga

Canada to lift restrictions on gay men donating blood

Health Canada has lifted restrictions on gay men donating blood, a move Prime Minister Justin Trudeau says is “good news for all Canadians” but took too long

The Independent UK

5 Resilient Stocks to Buy for a Market Downturn

Yesterday, the broad market indices closed in negative territory on interest-rate-increase concerns. Goldman Sachs has predicted that the S&P might tumble to 3,600 this year if recessionary pressure persists. Non-cyclical stocks usually perform well during economic downturns. So, we believe Cardinal Health (CAH), Brookfield Infrastructure Corp. (BIPC), Smith & Nephew…

StockNews.com

From analysis to the latest developments in health,
read the most diverse news in one place.

Sproutly Forms Joint Venture With Kingston Cannabis, Here Is Why

Sproutly Canada, Inc. (OTCQB: SRUTF) (CSE:SPR) (FSE: 38G), is expanding its commercial relationship with Kingston Cannabis Inc., a Health Canada Licensed processor.

Benzinga

Health Canada Approves Grapefruit USA's Hourglass Time Release THC+CBD Delivery Cream For Sale

Grapefruit USA, Inc. (OTCQB: GPFT), announced that its notice of new cannabis product (“NNCP”), filed with Health Canada on Jan.

Benzinga

Delic Labs Receives Exemption To Conduct Research On MDMA, LSD And Other Psychedelic Compounds

Delic Labs subsidiary of Delic Holdings Corp (OTCQB:DELCF) (CSE:DELC) (FRA: 6X0), received a Health Canada 56 research exemption that will allow scientists to conduct research and perform tests on a number of compounds outside of psychedelic mushrooms, including MDMA, LSD, DMT, mescaline and 2C-B. Additionally, Delic Labs has received a…

Benzinga

Adastra Submits Medical Sales License Application And Engages IR Labs To Provide Investor Relations Services

Adastra Holdings Ltd. (OTCPK:XTXXF) (CSE:XTRX) (FRA:D2EP) submitted medical sales license application to Health Canada on April 1, 2022. A medical sales license would permit Adastra to perform the following activities:

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Nova Mentis Is Looking To Treat Autism With Psilocybin

Nova Mentis Life Science Corp. (OTCQB:NMLSF) and the private college Toronto Institute of Pharmaceutical Technology have signed a contract for the production of psilocybin capsules. The company will supply the microdose capsules for a Phase 2A fragile X syndrome (FXS) clinical study. FXS, also known as Martin-Bell syndrome, is one…

Benzinga

Canadian Cannabis Producers Are Financially Squeezed: Unpaid Marijuana Fees Grow 10X YoY To CA$914K

Has competition in the Canadian cannabis market finally reached its climax?

Benzinga

Hempsana Teams Up With GAMA To Launch New Cannabis Product Offerings And Brands

Hempsana Holdings Ltd. has entered into a contract manufacturing agreement with GAMA Corp to co-manufacture and distribute new products and brands from the United States to the Canadian and International Markets for both recreational and medicinal use.

Benzinga

Adastra Holdings Approved For Dealer's License For Psilocybin, Psilocin, MDMA, DMT, 5-MeO-DMT & LSD

Adastra Holdings Ltd. (OTCPK: XTXXF) (CSE: XTRX) (FRA: D2EP) recently completed the submission of its application for a controlled drugs and substances dealer's license. What Does It Mean?

Benzinga

Health Canada Approves Moderna's COVID-19 Vaccine For Kids Aged 6-11 Years

Health Canada has approved Moderna Inc's (NASDAQ:MRNA) mRNA COVID-19 vaccine, Spikevax, two-dose series of 50 µg per dose to prevent COVID-19 in children aged six to11 years. The announcement follows the recent authorization of the Company's COVID-19 vaccine in the same age group in both Australia and the European Union. "Health Canada was…

Benzinga

Pure Extracts Exports First Shipment Of Cannabis Oil Extracts To German Pharma

Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) has successfully exported its first batch of cannabis oil extracts to a German pharmaceutical company under a Health Canada export permit.

Benzinga

RYAH Medtech Secures Health Canada Medical Device License For Its Medical Cannabis Inhaler System

RYAH Medtech, Inc. subsidiary of RYAH Group, Inc. (CSE:RYAH) has received a Health Canada medical device license for its proprietary internet of things powered medical cannabis inhaler, proprietary cartridges and software application associated with the device.

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Tetra Bio-Pharma Gets Health Canada's Approval To Use 100mg Of CBD In Inhaled Cannabidiol Safety Study

Health Canada approved the amendment of a phase I study by Tetra Bio-Pharma Inc. (TSX:TBP) (OTCQB: TBPMF) (FRA: JAM1) conducted in collaboration with Dr.

Benzinga

Hempsana Holdings Receives Health Canada's Approval To Sell Medical Cannabis Directly To Patients Across Canada

Hempsana Holdings Ltd. has received its medical sales license from Health Canada which provides the company the ability to sell cannabis products directly to medical patients across Canada.

Benzinga

HYTN Innovations Receives Health Canada's Approval To Sell Cannabis

HYTN Innovations Inc.’s (CSE:HYTN) subsidiary HYTN Cannabis Inc., has awarded a license amendment by Health Canada allowing for the sale of cannabis extract, edible cannabis, and cannabis topical products to provincially and territorially authorized retailers.

Benzinga

Novavax's COVID-19 Vaccine Scores Canadian Approval

Health Canada approves Novavax Inc's (NASDAQ: NVAX) Nuvaxovid COVID-19 Vaccine in individuals 18 years of age and older.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Magic Mushrooms For Depression: Clinical Trial Of Active Compound Approved For Patients Using Antidepressants

Health Canada has allowed a phase 2 clinical trial of psilocybin in patients currently undergoing treatment with traditional antidepressants.

Benzinga

Canada Approves Pfizer's At-Home COVID-19 Antiviral Treatment, But Deliveries Delayed

Health Canada approved Pfizer Inc's (NYSE: PFE) oral antiviral treatment for mild to moderate cases of COVID-19 in adults.

Benzinga

Blackhawk's MindBio Therapeutics to Develop Psychedelic Medicine in Microdoses Ready for Commercial Use to Treat Major Depressive Disorder

Vancouver, British Columbia - TheNewswire - January 17, 2021 – Blackhawk Growth Corp. (CSE:BLR) (CSE:BLR) (OTC:BLRZF) (Frankfurt:0JJ) (the "Corporation" or "Blackhawk") is pleased to announce that its wholly-owned subsidiary MindBio Therapeutics Pty Ltd ("MindBio") is developing a new microdosing formula using LSD (Lysergic Acid Diethylamide) to treat Major Depressive Disorder…

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Vertex Pharmaceuticals Incorporated

63 stories

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.